Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMATINIB vs IMETELSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMATINIB vs IMETELSTAT: Safety Overview

Metric IMATINIB IMETELSTAT
Total FAERS Reports 43,161 137
Deaths Reported 13,761 18
Death Rate 31.9% 13.1%
Hospitalizations 7,264 37
Average Patient Age 55.7 yrs 77.0 yrs
% Female Patients 47.2% 43.3%
FDA Approval Date Apr 14, 2025 Jun 6, 2024
Manufacturer Dr.Reddy's Laboratories Inc Geron Corporation
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription